Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Patrick Honeycutt

Podiatrist, Foot & Ankle Surgery Cutler Bay, FL Doctor of Podiatric Medicine

NPI 1356703185 CMS profile 2455569

18430 S Dixie Hwy, Cutler Bay, FL 33157

Open in the dashboard

General payments

$10,697

152 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Patrick Honeycutt of Cutler Bay, FL is reported in the CMS Open Payments database as having received $10,697 across 152 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,217 16
2024 General $2,803 30
2023 General $1,739 30
2022 General $1,312 26
2021 General $453 16
2020 General $789 17
2019 General $385 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Patrick Honeycutt
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Patrick Honeycutt were reported at $3,217. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Patrick Honeycutt Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $385 $389 $118–$1,406 $163
2020 $789 $191 $62–$691 $114
2021 $453 $329 $104–$1,341 $132
2022 $1,312 $419 $125–$1,611 $149
2023 $1,739 $377 $128–$1,164 $160
2024 $2,803 $394 $134–$1,168 $164
2025 $3,217 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $3,716 36 payments
  2. Integra LifeSciences Corporation $2,625 18 payments
  3. Smith+Nephew, Inc. $1,076 41 payments
  4. Treace Medical Concepts, Inc. $1,032 3 payments
  5. Musculoskeletal Transplant Foundation Inc. $463 2 payments
  6. Aroa Biosurgery Incorporated $338 2 payments
  7. In2Bones USA, LLC $149 1 payment
  8. Organogenesis Inc. $139 2 payments
  9. Horizon Therapeutics plc $136 4 payments
  10. AbbVie, Inc. $92 4 payments
  11. Other $931 39 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,118 138 payments
  2. Travel and Lodging $3,531 11 payments
  3. Long term medical supply or device loan $1,747 2 payments
  4. Consulting Fee $300 1 payment
Products named General payments · program years 2019–2025
  1. AMNIOEXCEL PLUS $1,502 1 payment
  2. ORTHOLOC 2 LAPIFUSE $963 8 payments
  3. Integra Recon-Skin And Wound $859 15 payments
  4. Integra Recon-Skin And Wound $859 15 payments
  5. PRIMATRIX $859 15 payments
  6. Integra Recon-Skin And Wound $859 15 payments
  7. INTEGRA DERMAL REGENERATION TEMPLATE $859 15 payments
  8. PROSTEP MICA $817 3 payments
  9. LAPIPLASTY $797 2 payments
  10. PROSTEP $772 5 payments
  11. Other $5,229 143 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 23 drugs

Part D claims

1,481

Median for Podiatry: 160

Drug cost

$42,488

Median for Podiatry: $2,368

Branded share of claims

32%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Jublia Efinaconazole Brand 15 $11,018
Ciclopirox Generic 284 $9,877
Ammonium Lactate Generic 237 $5,293
Fluorouracil Generic 49 $4,111
Diclofenac Sodium Generic 45 $1,916
Ketoconazole Generic 94 $1,841
Lidocaine-Prilocaine Lidocaine/Prilocaine Brand 128 $1,717
Ciclopirox Ciclopirox Olamine Brand 156 $1,464
Gentamicin Sulfate Generic 27 $1,281
Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip Brand 49 $821

The 10 drugs with the highest cost, of 23 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$211,761

Medicare's payments for the services billed

Medicare patients

257

Average age 73

Services billed

1,068

133 women, 124 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 65%
Diabetes 62%
Chronic kidney disease 46%
Ischemic heart disease 40%
Depression 33%
Heart failure 30%
Atrial fibrillation 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

152 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record